CClinicalTrials.gg
CompletedNCT04757077Updated Jul 14, 2021

The Association Between Pelvic Floor Muscle Function, Diastasis Recti and Postpartum Pelvic Girdle Pain - a Matched Case Control Study.

An observational study in Pelvic Girdle Pain, Diastasis Recti and Weakness of the Linea Alba and Pelvic Floor Disorders, sponsored by Żelazna Medical Centre, LLC. Completed at 1 site in Poland. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-14.

Sponsored by Żelazna Medical Centre, LLC · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
56
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Background: Pregnancy-related pelvic girdle pain (PGP) can appear during pregnancy, directly after labour or can be delayed to 3 weeks postpartum. Pain is experienced between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the sacroiliac joint (SIJ). The pain may radiate in the posterior thigh and can also occur in conjunction with/or separately in the symphysis. The endurance capacity for standing, walking, and sitting is diminished. The diagnosis of PGP can be reached after exclusion of lumbar causes. The pain or functional disturbances in relation to PGP must be reproducible by specific clinical tests. Lack of accurate and early diagnosis of the PGP postpartum may contribute to development of chronic condition, lowering quality of life years after delivery. There is uncertainty regarding the association between the function of the pelvic floor muscles (PFM), diastasis recti and postpartum pelvic girdle pain (PGP). Although widely researched abroad, there is a paucity in research about biopsychosocial profile of women with postpartum PGP in Poland.

Objectives: The aim of this one-to-one matched case-control study it to examine whether there is any difference in PFM function and diastasis recti between women with and without clinically diagnosed PGP. Additionally, differences in biopsychosocial profile (depression, anxiety, stress, catastrophizing and kinesiophobia) will be assessed.

Materials and methods: Because of low incidence of researched condition, a case control study will be the study design of choice. Women 6-24 weeks after delivery with postpartum PGP will be matched with those with no PGP. Subjects' assessment will consist of palpation examination of diastasis recti (inter-recti distance) and pelvic floor muscles. Perineometry of the pelvic floor will also be conducted. Additionally, several questionnaires for the assessment of mental processing will be used: Depression Anxiety Stress Scale 21, Pain Catastrophizing Scale and Tampa Scale of Kinesiophobia. Participants will be matched according to age, parity and time postpartum.

Expected results: To our knowledge, postpartum pelvic girdle pain has not been extensively studied in Poland so far. The study will bring information about the possible associations with postpartum PGP. We hypothesize that the study will confirm our clinical observations about pelvic floor dysfunction and maladaptive mental processing in women with postpartum PGP.

02

Conditions studied

  • Pelvic Girdle Pain
  • Diastasis Recti and Weakness of the Linea Alba
  • Pelvic Floor Disorders
03

In context

Diastasis, Muscle

41 studies on the registry are indexed under Diastasis, Muscle; 9 are open to participants now.

This study's enrollment of 56 is close to the median of 53 across 10 observational studies indexed under Diastasis, Muscle.

Browse Diastasis, Muscle studies →

Lead sponsor

Żelazna Medical Centre, LLC is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women, 6-24 weeks after delivery

Inclusion criteria

  • Vaginal labour (including vacuum extractor or forceps) or caesarean section
  • For group with PGP: pain due to PGP
  • For control group with no pain - no pain due to PGP
  • Agreement to participate

Exclusion criteria

Exclusion Criteria:

  • Diseases that can mimic PGP f.ex. Scheuermann disease, rheumatoid arthritis, Ehler's-Danlos Syndrome, hip dysplasia.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
56 participants (actual)
Patient registry
No

Groups and cohorts

  • GROUP 1

    Patients 6-24 weeks after delivery with postpartum PGP (Patients with symptoms and signs of PGP, PGP confirmed with dedicated functional tests).

  • GROUP 2

    Patients 6-24 weeks after delivery, with no symptoms and signs of PGP.

06

What researchers measure

Primary outcomes

  1. Perineometry of the pelvic floor - vaginal resting pressure.

    Measurement of the vaginal resting pressure.

    Time frame: one time assessment, 6-24 weeks after delivery

  2. Perineometry of the pelvic floor - vaginal squeeze pressure.

    Measurement of the vaginal squeeze pressure.

    Time frame: one time assessment, 6-24 weeks after delivery

  3. Palpable measurement of inter-recti distance (IRD)

    Palpable measurement of inter-recti distance (IRD)

    Time frame: one time assessment, 6-24 weeks after delivery

Secondary outcomes

  1. Perineometry of the pelvic floor - endurance

    Pelvic floor endurance measurement (area under the curve).

    Time frame: one time assessment, 6-24 weeks after delivery

  2. Diastasis Recti: palpation examination of the stability of the linea alba

    Assesment of the stability of the linea alba during abdominal crunch - bulging means that it is unstable

    Time frame: one time assessment, 6-24 weeks after delivery

  3. Palpation examination of pelvic floor muscles with the use of PERFECT Scheme

    Assesment of pelvic floor muscles with the use of PERFECT Scheme

    Time frame: one time assessment, 6-24 weeks after delivery

  4. Pain Catastrophizing Scale

    Assesment of Catastrophizing. It consists of 13 items rated on 5- point scale (0-not at all, 4-all the time). The score range is 0-52. Higher scores indicates higher amounts of pain catastrophizing.

    Time frame: one time assessment, 6-24 weeks after delivery

  5. Depression Anxiety Stress Scale 21

    Assesment of Catastrophizing. It is a self-report scale which consists of 21 items and 4-point severity scales (0- did not apply to me at all, 3-applied to me very much, or most of the time). Total scale thus range between 0 and 120, and those for each of the subscales may range between 0 and 42. Moderate outcomes indicates elevated depression, anxiety, or stress.

    Time frame: one time assessment, 6-24 weeks after delivery

07

Study locations

1 site
  • St. Sophia's Specialist Hospital
    Warsaw, 01-004, Poland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04757077
Lead sponsor
Żelazna Medical Centre, LLC
Responsible party
Sponsor
First posted
Feb 16, 2021
Start date
Feb 22, 2021
Primary completion
May 31, 2021
Completion
May 31, 2021
Last update
Jul 14, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion